Salivary Biomarker Applications in Disease Diagnostics

Saliva has emerged as a compelling non-invasive medium for the detection and monitoring of a wide spectrum of diseases. Its direct anatomical connections with oral, digestive and endocrine systems support the presence of locally secreted and systemically derived molecules. Advances in high-sensitivity analytical platforms have enabled the detection of proteins, nucleic acids, metabolites and extracellular vesicles at concentrations once deemed too low for reliable measurement. Salivaomics integrates proteomic, transcriptomic, metabolomic and microbiome data to capture a multidimensional signature of health status. Such signatures offer opportunities for early disease detection, prognosis, therapeutic monitoring and risk stratification across oral pathologies, metabolic syndrome, cancer and neurodegenerative disorders. Point-of-care implementation utilising microfluidic and smartphone-compatible devices promises rapid results in decentralised settings, potentially transforming personalised and preventive medicine. Global interest is driven by the ease of self-collection, reduced biohazard risk and minimal requirement for specialised personnel or infrastructure, making salivary diagnostics particularly attractive for large-scale screening programmes and resource-limited environments.

Research from Nature Portfolio

Standardised methodologies for saliva collection and processing have been shown to be critical for reproducible biomarker analysis. One seminal study developed sensitive immunodetection assays for pain-related mediators, revealing novel isoforms of nerve growth factor, calcitonin gene-related peptide and brain-derived neurotrophic factor in human saliva. The work demonstrated significant variation in marker expression depending on collection technique and established a positive correlation between stimulated whole saliva levels of glutamate and paired blood samples. These findings underscore the importance of methodological consistency and pave the way for reliable salivary assessment of neurogenic and inflammatory processes.

Salivary Biomarker Applications in Disease Diagnostics publication trend

The graph below shows the total number of articles in salivary biomarker applications in disease diagnostics across all publications each year (not limited to Nature Index journals).

Technical terms

Biomarker: A measurable indicator of biological or pathogenic processes, or pharmacological responses to a therapeutic intervention.

Salivaomics: The holistic study of saliva’s molecular constituents, encompassing proteome, transcriptome, metabolome and microbiome analyses.

Proteomics: Large-scale identification and quantification of proteins expressed in a sample under defined conditions.

Transcriptomics: Comprehensive profiling of all RNA transcripts produced by the genome at a given time or condition.

Exosome: Nano-sized extracellular vesicle released by cells, carrying proteins, lipids and nucleic acids for intercellular communication.

Point-of-care diagnostic: Testing conducted at or near the site of patient care, designed to deliver rapid, actionable results.

Microfluidic device: A system of micro-scale channels and chambers enabling precise manipulation and analysis of minute fluid volumes.

Liquid biopsy: Non-invasive sampling of bodily fluids to detect and characterise disease-associated biomarkers, often for cancer diagnostics.

References

1. Promising applications of human-derived saliva biomarker testing in clinical diagnostics. International Journal of Oral Science (2023).
2. Saliva-based microfluidic point-of-care diagnostic. Theranostics (2023).
3. Salivary analysis: An emerging paradigm for non‐invasive healthcare diagnosis and monitoring. Interdisciplinary Medicine (2023).
4. Saliva as a medium to detect and measure biomarkers related to pain. Scientific Reports (2018).